Skip to site menu Skip to page content
PIERRE FABRE CDMO Supercritical Fluids

Subscribed

You have successfully submitted your enquiry. Someone from our company will respond ASAP

Patented Drug Delivery Technologies: FORMULPLEX and FORMULCOAT

Based on our know-how in supercritical fluids, we have developed a multi-purpose technology platform. Today, three main technologies are available from development to commercial production: nanoparticles, FORMULPLEX® and FORMULCOAT®.

NANOPARTICLES

Enhancing the dissolution rate by increasing the surface specific area of an API. RESS, SAS or PGSS can be used to produce nano or micro-sized particles with a narrow size distribution with a mastered crystalline form.

FORMULPLEX

FORMULPLEX is a cyclodextrin complexation using supercritical fluids. Two processes have been developed and patented to enhance the bioavailability of a poorly-soluble API. FORMULPLEX1® is a one-step process, easy to develop and scale-up. FORMULPLEX3® is a three-step process usually used to reach a higher ratio of complexation.

Compared to complexation in water, supercritical CO2 offers different advantages in terms of complexation ratio.

FORMULCOAT

FORMULCOAT is a taste or smell-masking, API protection or stabilisation, slow release system. Our patented process allows the coating of micro or nano-sized particles at room temperature with no organic solvent. The productivity is the main strength of the process: 2kg of API can be coated in only three minutes.

Pierre Fabre Medicament active ingredient division will be participating in the following events:

  • BioSquare, Lyon (France), 12th to the 14th of March
  • BioPharmos, Monaco (France), 20th to the 21st of March
  • CPhI Japan, Tokyo (Japan), 18th to the 20th of April
  • BIO, Boston, MA, USA, 7th to the 8th of May

For more information about Pierre Fabre Medicament active ingredient division, please click the link below.

Related Content